SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

She’s a pediatrician, an asthma researcher at Harvard Medical School, and the mom of a 14-year-old who’s had asthma since she was a toddler, so Ann Chen Wu, M.D., knows how to look at asthma from ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an eosinophilic phenotype, according to a press release from GSK.Depemokimab ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...

More than 24 million Americans have been diagnosed with asthma, and 10 percent of them have a tough time controlling it, even with treatment. But a new form of therapy -- known as biologic -- is ...

Six million American kids now have asthma—twice as many as 20 years ago. This mysterious epidemic panics parents, confounds doctors, and sends nearly 700,000 kids to the ER each year with I can't ...

Asthma is a lifelong condition with no cure, but there are many ways to manage your symptoms. Short-acting medications help you breathe when you’re having an attack. Long-term drugs work to keep ...